CD4 and neoplasm: Patients with B7-H2high tumor cells showed advanced TNM stage and N+ stage with decreased OS, MFS, or DFS, and this sub-cohort was featured with a trend of diminished CD4+ T cells and CD8+ cells in tumor center in situ, which positively correlated with PD-L1 and IL10 [41].